Author

A. Zingg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1 Approach:deep learning· 1

Frequent Co-Authors

A. Boersch· 1 shared A. Zippelius· 1 shared B. Eicher· 1 shared C. A. Guzman· 1 shared C. Esslinger· 1 shared C. Townsend· 1 shared D. Lardinois· 1 shared E. Carlini· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Boersch

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Engagement of sialylated glycans with Siglec receptors on myeloid suppressor cells inhibit anti-cancer immunity via CCL2

R. Wieboldt, E. Carlini, L. Chia-wei, A. Boersch, A. Zingg, D. Lardinois, P. Herzig, L. Don, A. Zippelius, H. Laeubli, N. Rodrigues Mantuano

This study shows that sialylated glycans on myeloid suppressor cells interact with Siglec receptors to suppress anti-cancer immunity through CCL2-mediated mechanisms.

bioRxiv · Jun 29, 2023 · PreprintImmunology

MTX-COVAB, a human-derived antibody with potent neutralizing activity against SARS-CoV-2 infection in vitro and in a hamster model of COVID-19

C. Esslinger, S. Schmitt, M. Weber, M. Hillenbrand, J. Seidenberg, A. Zingg, C. Townsend, B. Eicher, J. Rutkauskaite, P. Riese, C. A. Guzman, K. Fischer

The paper identifies a human-derived monoclonal antibody, MTX-COVAB, with potent neutralizing activity against SARS-CoV-2 in vitro and in a hamster model, showing efficacy against variants and readiness for clinical testing.

bioRxiv · Dec 1, 2020 · PreprintImmunology

Synthetic standards combined with error and bias correction improves the accuracy and quantitative resolution of antibody repertoire sequencing in human naive and memory B cells

S. Friedensohn, J. M. Lindner, V. Cornacchione, M. Iazeolla, E. Miho, A. Zingg, S. Meng, E. Traggiai, S. T. Reddy

bioRxiv · Mar 21, 2018Immunology